LCM
PHAT icon

Landscape Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Landscape Capital Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,940
Closed -$136K – 929
2023
Q4 		$136K Buy
+14,940
New +$129K 0.01% 746

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Landscape Capital Management's PHAT Position: Q1 2024 in Review

Landscape Capital Management sold out of Phathom Pharmaceuticals (PHAT) in Q1 2024, closing a stake of 14,940 shares — an estimated $136K sold.

Landscape Capital Management first reported a position in PHAT in Q4 2023 and held it in 1 quarter. The position peaked at $136K in Q4 2023. 114 funds tracked by Wall St. Rank hold PHAT as of Q1 2024.

  • Landscape Capital Management reported no remaining Phathom Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Landscape Capital Management sold 14,940 Phathom Pharmaceuticals shares in Q1 2024, an estimated $136K.
  • Landscape Capital Management first reported a position in Phathom Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • Landscape Capital Management's Phathom Pharmaceuticals position peaked at $136K in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2024.

Based on Landscape Capital Management's 13F filing for Q1 2024, filed 9 May 2024.